29-Apr Outline. Automation in dissolution testing. Mumbai , May 4 Samir Haddouchi
|
|
- Kelley O’Brien’
- 5 years ago
- Views:
Transcription
1 Automation in dissolution testing Mumbai , May 4 Samir Haddouchi samir.haddouchi@sps-pharma.com 1 Outline - Introduction about automation - Automation for dissolution testing - Validation of automated methods - Case studies 2 Automation is already present everywhere in a pharmaceutical laboratory! Who is injecting manually samples onto the HPLC? Compared to all other techniques used, HPLC is still considered as a major and noble technique. However, several other automated systems are available and widely used: Automated physical testing Automated dissolution systems Automated sample preparation systems Mainly for labor savings!! 3 1
2 Why using automated systems? - Productivity - Time to market - Quality - Operator safety 4 Productivity (1) Most obvious reason to invest on automated systems! Automated systems can operate a defined process without any interaction of the analyst. This releases time for other added-value activities (ie paperwork ). Few full time equivalents may be gained in this manner. 5 Productivity (2) The return of investment is usually quite easy to evaluate based on the salary. However, the savings can be considered as "static". The only way to improve continuously the situation is to make additional investments. However, the objective of such investment is rarely to reduce the headcount! 6 2
3 Why using automated systems? - Productivity - Time to market - Quality - Operator safety 7 Time to market Instead of the previous situation where the aim was to carry out more analyses throughout the year, automation can also help to dicrease the impact of time-consuming steps. In production, the time needed to release a batch is reduced and therefore the following steps can be done with no risk (ie packaging, shipment, etc ). In development, automated systems (especially dissolution) can support the formulation development by analyzing different variants overnight and giving the opportunity to improve the formula the day after 8 Why using automated systems? - Productivity - Time to market - Quality - Operator safety 9 3
4 Analytical quality (1) Be careful to the difference between: - Quality - Quality Assurance!! What is the goal when developing a characterization method for a product? To ensure that the data generated reflect the quality of the product and are not related to the quality of the method! 10 Analytical quality (2) Recently, USP published several papers on the influence of different factors and parameters on the results of Prednisone calibration!! One of the main reason identified to be a root cause on non compliant results was the operator. By using automated systems, one can eliminates this variable and therefore ensure having an overall better method. 11 Quality Assurance Rough estimation of the cost for an OOS report : 1'500 $ (lost time, paper work, etc ) Some companies handle hundreds of such reports!! Using automated systems can also help minimizing the risk of analytical errors or mix-ups. This is an area of concern for the FDA. It is easier to audit a secured database than a lab book and what about auditing any human brain!! FDA officials say: «If you didn t document it, it didn t happen. In God we trust, for everyone else we require documentation». 12 4
5 Why using automated systems? - Productivity - Time to market - Quality - Operator safety 13 Safety Some active ingredients used in the pharmaceutical domain are extremely dangerous: - cytotoxics - cytostatics - nanoparticles - highly potent drug, etc The mass opinions are no more accepting the idea of risk. Automated systems can help avoiding employees exposure to such products. 14 Outline - Introduction about automation - Automation for dissolution testing - Validation of automated methods - Case studies 15 5
6 Automated sampling This is the first step in automation. Allows to perform sampling automatically i.e. over night. Samples can be stored in tubes or vials for a further quantification (also called off-line) Or measurements can be done online (UV-Visible photometry) and then the results are available "on the fly" (more cost effective) 16 USP2 instrument online 17 Fully automated systems Allow to automate: - the preparation of the test (heating, degassing and filling the dissolution media in the vessels) - the dissolution test itself (with offline collection or online readings) - The cleaning of the system to be able to start another test All these steps should be done without user interaction. These systems are more expensive than a semi automated system but they allow to have one single operator producing 10 to 15 dissolution tests per day and moreover, tests could be done during week ends 18 6
7 Fully automated systems 19 Outline - Introduction about automation - Automation for dissolution testing - Validation of automated methods - Case studies 20 Filtration Filtration Aim: Confirms that the drug tested does not adsorb onto the filter. Procedure: Manually filtered samples and automated filtered samples are compared. 21 7
8 Cleaning Cleaning verification Aim: Confirms that automated cleaning cycle is sufficient to prevent carryover. Procedure: Run a normal dissolution, followed by a blank run. 22 Cross validation Cross validation Aim: Confirms that automated results are not significantly different than manual results. Procedure: Run dissolution on your current systems, then on the automated (minimum n=3 batches) Possible issue: Is the variability observed due to the product or to the method? 23 Outline - Introduction about automation - Automation for dissolution testing - Validation of automated methods - Case studies 24 8
9 Acknowledgements Sean Space Pfizer US Emmanuel Scheubel Roche CH Krystyna Pobloka Teva Canada 25 Pfizer Case Studies Varenicline Film-Coated Tablets Approved nicotinic receptor partial agonist smoking cessation. Approved in over 60 countries BCS Classification 1 Lasofoxifene Lasofoxifene (high potency compound) is an estrogen receptor agonist Feasibility and validation of the use of SOTAX for dissolution testing Cetirizine HCl Cetirizine hydrochloride (Zyrtec) is an orally administered selective H 1 receptor antagonist approved for treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. Query response 26 Varenicline Tartrate 2 dosage strengths subjected to SUPAC screen Aberrant and variant dosage forms evaluated with selected conditions Apparatus USP <711> Dissolution Apparatus I (baskets) and Apparatus II (paddles) Media 500 ml of water 500 ml of 0.01N HCl 500 ml of 0.1N HCl 500 ml of ph 4.5 buffer 500 ml of ph 6.8 buffer Basket Speed 50 and 100 rpm Paddles speed 50, 75 and 100 rpm Total number of dissolution runs 340 in 3 months 27 9
10 Varenicline: Why automation? SOTAX system used to: Evaluate effects of agitation, media, and apparatus type on the release characteristics of 0.5 and 1.0 mg tablets 5 media, 2 paddle speeds, 2 basket speeds Evaluate release characteristics of aberrant/variant tablets Used to analyze ICH and Site Validation stability studies (4 lots of each strength in 3 packaging configurations each) Over 600 analyses in one quarter Approved in 71 countries Launched in 48 countries 28 Validation Protocol for Lasofoxifene Validation Parameters Linearity/Recovery Reproducibility/Carryover Filter validation Dissolved oxygen SUPAC media screen Paddle type Dissolution Conditions USP Apparatus 2 Temperature: 37 C ± 0.5 C Rotation Speed: 75 RPM Dissolution Media: 0.01N HCl 500 ml of media/vessel 5, 10, 20, 30 min. sample pulls Over 25 analyses were performed at the various validation conditions. 29 Summary of Validation Results Linearity met acceptance criteria (R 2 = ) Reproducibility met acceptance criteria (% RSD of the average % 20 minutes of 6 consecutive runs = 3.3%) Carryover met acceptance criteria (< 2% carryover after 6 consecutive runs) Filter validation demonstrated by successful recovery Dissolved oxygen results reported and plotted (no differences between fully aerated media and deaerated media) SUPAC media screen has not been assessed QC wishes to use a SOTAX AT-70 for automated dissolution testing for commercial lots of lasofoxifene tablets. Due to this feasibility and validation work, this is possible
11 Cetirizine Chewable Tablet Hardness Study 96 Lots x 2 Time points / Lot = 192 Disso Runs 3 Runs / Day = 64 Days (This is an optimistic estimate!) Using Automated Disso = 28 days Actual = 36 day Savings* * Sotax AT70 initially running 4 Lots / day as learning curve leveled we were able to run 9 Lots / day for a potential saving of 43 days 31 Metric analysis Varenicline Cetirizine 20 0 Automation(dissolution runs per month with analysis) Manual (Estimate 12 runs per week)) 32 Roche Case Studies Case Study #1 : Ileum release enteric coated tablets Case Study #2 : HPLC On-line 33 11
12 Ileum enteric coated tablets % dissolved time (min) GTS 0073/03 S100/Talcum 100/50-7 mg in 2 media P50 GTS 0073/03 S100/Talcum 100/50-13 mg in 2 media P50 Different enteric coating thickness for Ileum release GTS 0073/03 S100/Talcum 100/50-4 mg in 2 media P50 GTS 0073/03 S100/Talcum 100/50-10 mg in 2 media P50 According to USP <711> resp. P.E 2.9 : no release 2 ph 1.1 and neutral ph 34 Ileum enteric coated tablets 35 Ileum enteric coated tablets Preprandial = fasted state ph and residence times in various segments of the GI tract Segment ph MRT (tablets) 1 Dissolution Method Design: stomach 1.8 (1-3) 60 min HCl - 1 h duodenum 6.0 (4-7) < 10 min upper jejunum 6.5 (5.5-7) 30 min ph 6.0-1h lower jejunum 6.8 (6-7.2) 30 min upper ileum 7.2 ( ) 60 min lower ileum 7.5 (7-8) 120 min proximal colon hours 1 non-disintegrating tablets ph 7.0-2h ph and mean residence time in various segments of the of fasted GI tract: (Source J.B. Dressman et al., University Frankfurt 2005) enteric coating 36 12
13 Ileum enteric coated tablets 1 ph change 2 ph change s ph level method ph level method ph ph 3 2 ph residence time (min) 3 2 ph residence time (min) 37 Ileum enteric coated tablets: Set up of the system for 2 ph changes Product name 38 Ileum enteric coated tablets % dissolved time (min) GTS 0073/03 S100/Talcum 100/50 P 4 mg 3 media GTS 0073/03 S100/Talcum 100/50 P 7 mg 3 media Different enteric coating thickness for Ileum release Conclusion: One coating was clearly not tight enough for the ileum release purpose. Automation was the only solution for this highly complex 2 ph changes method with full change. The method can be easily implemented in routine and provides potential for IVIVR/C investigations
14 Ileum enteric coated tablets Enhancement of capacity has to be calculated with all activities: preparation and cleaning of system as well as documentation and archiving Benefit of fully automated process No. of run Manual Sotax AT-70 1 ph change Sotax AT-70 2 ph changes 1 1 day 1 day 1 day 4 4 days 2 days 2 days 8 8 days 4 days 4 days At least a factor 2 can be reached & a heavy manual handling can be overcome 40 Dissolution & HPLC On-line HPLC measurement is the main limiting time factor in dissolution testing. Typical dissolution profile time for IR : 1 H with 5 sampling = 30 samples Typical HPLC run time for dissolution = 5 Typical HPLC sequence with SST = 40 injections = 200 = 3.3 hours Manual Off line process 2-3 dissolution testing /day measurements over night (with maxi capacity of auto sampler) = 10 hours of analysis (can be critical for non stable solutions) First enhancement step = HPLC Online 41 Dissolution & HPLC On-line Sotax AT70smart fitted with TS70 Option and Kloen Typical dissolution run time with LC on line = 3.5 hours HPLC on line process 3-4 dissolution testing /day sequential runs = 15 hours of analysis (can be critical for non stable std solutions) 2nd enhancement step = Fast HPLC 42 14
15 Dissolution & HPLC On-line 4.6*50 mm, 3.5 µm, 1.5 ml/min, 40 C; 70 bars Retention time: 3.4 min LC run time 4` 43 Dissolution & HPLC On-line 2.1*50 mm, 1.8 µm, 1.0 ml/min, 70 C ; 400 bars Retention time: 0.6 min LC run time 0.8` 44 Dissolution & HPLC On-line HPLC measurements time decreased up to 30 / run Typical dissolution profile time for IR : 1 H with 5 sampling points Fast HPLC measurement time for 40 samples = 25 Typical dissolution run time with LC on line & 40 runs = 1.6 H (dissolution time + cleaning) On- line with fast HPLC 10 dissolution testing /day measurement over night Limitation = AT70 capacity!!!!!! (10 runs) 45 15
16 Dissolution & HPLC On-line Benefit of fully automated process No. of run Manual Off line Sotax AT-70 On-line HPLC Sotax AT-70 On-line + Fast HPLC day 1 day 1 day days 2 days 1 days days 3-4 days 2-3 days At least a factor 3 can be reached. Comparable to UV-on line with better selectivity (early phase API is not so well known and change frequency is high, that can be hazardous with UV) ideal choice for early phase 46 Cost Saving Evaluation Cost Saving in $CND/Batch Cost Saving in $CND/Year Product I $ $140,625 Product II $ $87,500 Product III $ $25, Conclusions Validation has been focused on high volume products. As a result of transfer to automated methods, time of release of the finish product decreased due to the overnight and weekend runs. Significant cost saving per batch (runs unattended - available resources for other tasks). Reduced number of the investigations due to lab errors (locked methods)
17 Thank you for your attention. SPS Pharma Services Orleans - France 49 17
Who we are? Dissolution testing of modified release forms. Dissolution testing of immediate/ modified release forms
Dissolution testing of modified release forms Mumbai - 2013, May 3 Samir Haddouchi samir.haddouchi@sps-pharma.com 1 Dissolution testing of immediate/ modified release forms Mumbai - 2013, May 3 Samir Haddouchi
More informationMethod Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology
Technical Overview Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology Introduction Online fiber-optic and multicell UV-dissolution systems have become increasingly
More informationAT 70smart Fully Automated Dissolution System
AT 70smart Fully Automated Dissolution System Fully automated from media preparation to data reporting Batch up to 40 lots of Apparatus 1 or 2 methods including the use of sinkers Powerful DoE screening
More informationDeveloping and Validating Dissolution Procedures for Improved Product Quality
W H I T E P A P E R Developing and Validating Dissolution Procedures for Improved Product Quality By Michael Swartz, Ph. D., Director of Research and Development, and Mark Emanuele, Chemist Abstract In
More informationOur design fits everywhere
Fully Automated System with Basket Station BS 60 Our design fits everywhere ISO 9001 Up to 15 unattended paddle dissolution tests (USP Apparatus 2) with the AT 70smart Paddle Station Up to 10 unattended
More informationTHE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION
THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION Pharmacopeial Forum Vol. 31(5)(Sept.-Oct. 2005) By : Mr. Seubpong Kumpusiri Mrs. Patima Maneesatid 26 May 2006 THE DISSOLUTION PROCEDURE: DEVELOPMENT
More information10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor
229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive
More informationA Simple and Economical Approach/Concept to Evaluate Quality of Pharmaceutical Products Based on an Improved Dissolution Testing Methodology
The Open Drug Delivery Journal, 2008, 2, 33-37 33 Open Access A Simple and Economical Approach/Concept to Evaluate Quality of Pharmaceutical Products Based on an Improved Dissolution Testing Methodology
More informationCE 7smart Flow-Through Dissolution System
CE 7smart Flow-Through Dissolution System In-vitro drug release testing in compliance with USP apparatus 4, EP, and JP Configurations for various methods and analytical requirements Specific flow-through
More informationAgilent TRS100 Raman. Quantitative Pharmaceutical Analysis System
Agilent TRS100 Raman Quantitative Pharmaceutical Analysis System Agilent TRS100 Raman Streamlined Quality Control Fast Test hundreds of intact tablets or capsules in minutes Simple Quantify active pharmaceutical
More informationAGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER VOLUME 16 ISSUE 4 PAGE 1 The 280-DS Mechanical Qualification System Not Just an Agilent Thing PAGE 3 You Asked, We Listened: New Inline Filtration for
More informationTransferring Dissolution Methods. Kenneth Boda Applications Engineer
Transferring Dissolution Methods Kenneth Boda Applications Engineer Agenda Prerequisites of a Method Transfer Transferring a Method to Automation Transferring a Method to Another Lab Determining Appropriate
More informationBCS, Biowaivers and Dissolution Test Methodologies
BCS, Biowaivers and Dissolution Test Methodologies Vinod P. Shah, Ph.D., FAAPS, FFIP Pharmaceutical Consultant, (Formerly with US FDA) North Potomac, MD., USA Disso Europe 2016 Romania Advances and Applications
More informationFor simple and accurate mechanical calibration.
For simple and accurate mechanical calibration. Regulatory Specifications and Recommendations Changes since 2007 in regulatory specifications now also allow enhanced mechanical calibration of dissolution
More informationApplication of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013
Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for
More informationInspection Trends. American Society for Quality Richmond, VA Section March 8, 2016
Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality
More informationBIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)
ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.
More informationPerformance Testing of Novel Dosage Forms
RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies
More information400-DS Dissolution Apparatus 7
400-DS Dissolution Apparatus 7 Unsurpassed Commitment to Innovation The 400-DS Dissolution Apparatus 7 is the result of Agilent s strong commitment to innovation in the areas of automation and integration
More informationIJPRD, 2013; Vol 5(02): April-2013 ( ) International Standard Serial Number
IJPRD, 2013; Vol 5(02): April-2013 (106 112) International Standard Serial Number 0974 9446 --------------------------------------------------------------------------------------------------------------------------------------------------
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More information"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY
"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo
More informationISSN India; g,secunderabad. Abstractt. a flow rate. of 1ml/min. di hydrogen. which acts. and chronic. including minimize (5) Figure
B.Lakshmi et al SPJTS,2013,1(1),015-023 RP-HPLC METHOD FOR THE QUANTIFICATION OF ROFLUMILAST IN FORMULATIONS ISSN 2321-4597 B..Lakshmi 1, Prof. T.V.Reddy 2 1.Kallam Haranadha Reddy Institute of Technology,NH-5,
More informationBIOEQUIVALENCE TRIAL INFORMATION
PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence
More informationDissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances
Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances Guidance for Industry U.S. Department of Health and Human
More informationConsultation response: Dissolution testing in BP finished products monographs for solid oral dosage forms
Consultation response: Dissolution testing in BP finished products monographs for solid oral dosage forms Background Oral dosage forms are the most convenient and widely used drug presentations. For solid
More informationAgilent 8453 Spectrophotometer and UV-visible ChemStation for Dissolution Testing. Solution Bundles for automated Dissolution Testing
Agilent 8453 Spectrophotometer and UV-visible ChemStation for Dissolution Testing Solution Bundles for automated Dissolution Testing General considerations UV benefits Simple, rugged and reliable equipment
More informationA Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC
Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate
More informationImplementation of PAT for Real Time Release Testing. Mark Smith Process Analytical Sciences Group Pfizer, Cork
Implementation of PAT for Real Time Release Testing Mark Smith Process Analytical Sciences Group Pfizer, Cork PAT at Pfizer A key enabler for transformational strategies and new quality paradigms 9 Delivering
More informationJournal of Atoms and Molecules
Review article Journal of Atoms and Molecules An International Online Journal ISSN 2277 1247 CLEANING VALIDATION IN PHARMACEUTICAL INDUSTRIES Abhishek Raj Senior R&D Officer, Quest Pharmaceuticals Pvt.
More informationRecent FDA Guidance For Industry; BCS Class 1 and 3 August 2015
Recent FDA Guidance For Industry; BCS Class 1 and 3 August 2015 Bryan Crist Scientific Affairs Manager, Agilent Technologies, Dissolution Systems Dissolution Exchange WebEx Bryan.crist@agilent.com August,
More informationUS FDAs Perspective on Product Quality and Bioequivalence
US FDAs Perspective on Product Quality and Bioequivalence Vinod P. Shah, Ph. D. Pharmaceutical Consultant (Formerly with US FDA) Scientific Principles in Dissolution Methodology and Drug Testing Society
More informationMedicines Control Authority Of Zimbabwe
Medicines Control Authority Of Zimbabwe BIOEQUIVALENCE APPLICATION FORM Form: EVF03 This application form is designed to facilitate information exchange between the Applicant and the MCAZ for bioequivalence
More informationReal-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology
Real-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology Authors: Piyush Patel A, Edward Godek B, Chris O Callaghan C, Dr. Ian Jones D A Colorcon, PA, USA
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer
More informationUSP 4 Flow-Through Dissolution Systems
MR and ER Tablets Medical Devices, Drug-Eluting Stents and Implants API s and Granules Suppositories and Soft Gelatine Capsules Microspheres, Microcapsules, Hydrogels and Liposomes Capsules and Pellets
More informationPractical Aspects of Dissolution Instrument Qualification a European Perspective
dx.doi.org/10.14227/dt180211p11 Practical Aspects of Dissolution Instrument Qualification a European Perspective e-mail: JKraemer@phast.com Johannes Kraemer* and Rolf Schwan PHAST, Kardinal-Wendel-Str.
More informationDissolution Market. Vinod Mehta
Dissolution Market Vinod Mehta Objective Dissolution - What is it? Market and Product Situation Carl Zeiss Offering System Packages Competition What is Dissolution Solid dosage form assays in the pharmaceutical
More informationQbD implementation in Generic Industry: Overview and Case-Study
QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They
More informationUSP s Perspective on Drug Product Performance Test
USP s Perspective on Drug Product Performance Test Course Overview 1. The concept of in vitro dissolution Definition and application 2. Compendial dissolution/ drug release testing 3. Method development
More informationInternational Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.7, No.1, pp ,
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304 Vol.7, No.1, pp 139-147, 2014-2015 Pharmaceutical Prospective Process Validation Of Chloroquiune Tablets Vilas S Jadhav*,
More informationManaging Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA
Managing Quality in Pharmaceutical Industry Using Six Sigma Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA Outlines Pharmaceutical Manufacturing Process and Drug Product Quality. Process Excellence Approach
More informationValidation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.
Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Varian, Inc. 2700 Mitchell Drive Walnut Creek, California 94598, USA www.varianinc.com Introduction Chromatographic
More informationDACLATASVIR TABLETS (DACLATASVIRI COMPRESSI) Proposal for The International Pharmacopoeia. (May 2018)
May 2018 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 DACLATASVIR TABLETS (DACLATASVIRI COMPRESSI) Proposal for The International
More informationApplication of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal Systems
dx.doi.org/10.14227/dt140207p25 Application of USP Apparatus 7 to In Vitro Drug Release in Scopolamine Transdermal Systems Marilyn X. Zhou 1, Duane Shoudt, Genaro Calderon, and Min Feng Analytical Research
More informationQUALITY OF PROLONGED RELEASE ORAL SOLID DOSAGE FORMS
QUALITY OF PROLONGED RELEASE ORAL SOLID DOSAGE FORMS Guideline Title Quality of Prolonged Release Oral Solid Dosage Forms Legislative basis Directive 75/318/EEC as amended Date of first adoption October
More informationVersion 3 Application Notes
Integrated Solutions Version 3 Application Notes Tablet Dissolution, Content Uniformity and Sample Preparation Automation unique automated analytical solutions for both UV and HPLC Analysis The IDISis
More informationTEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)
APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation
More informationDISSOLUTION TESTING OF GELS, TOPICAL CREAMS & OINTMENTS
AGILENT TECHNOLOGIES PRACTICAL SOLUTIONS NEWSLETTER VOLUME 15 ISSUE 4 PAGE 1 Dissolution Testing of Gels, Topical Creams & Ointments PAGE 4 Dispelling a Myth: 6- versus 12-Position Dissolution Units PAGE
More informationApplications of USP Apparatus 3: Reciprocating Cylinder
Applications of USP Apparatus 3: Reciprocating Cylinder Ken Boda Bryan Crist Agilent Technologies Current Trends in Pharmaceutical Dissolution Testing Workshop Pittcon 2015 Tuesday, March 10 Development
More informationUsharani Gundala* 1, Chandrashekar Bonagiri 2, Devanna Nayakanti 3
IOSR Journal Of Pharmacy (e)-issn: 2250-3013, (p)-issn: 2319-4219 www.iosrphr.org Volume 4, Issue 6 (June 2014), PP. 33-38 Simultaneous Estimation of Paracetamol and Tapentadol in Bulk and Pharmaceutical
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501, USA www.smatrix.com Introduction Chromatographic analytical
More informationMEDIS INTERNATIONAL a.s Praha 1, Olivova 4/2096 MEDIS PHARMA Bolatice. Industrial zone Bolatice, region of Opava, Czech Republic
MEDIS INTERNATIONAL a.s. 110 00 Praha 1, Olivova 4/2096 MEDIS PHARMA Bolatice Industrial zone Bolatice, region of Opava, Czech Republic In October 2008 MEDIS International a.s. started the building of
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationProposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>
Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding Ravi Ravichandran, Ph.D. Steve Zigler, Ph.D. February 21, 2011 Agenda Rationale for the
More informationOnline UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures
Online UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures Tanya Tollifson Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Online cleaning wash
More informationCleaning validation of cleanrooms and preparation equipments
Cleaning validation of cleanrooms and preparation equipments Dr Farshid SADEGHIPOUR Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About
More informationDissolution testing of solid oral dosage forms has
dx.doi.org/1.14227/dt22315p1 A Strategy for Quality Control Dissolution Method Development for Immediate-Release Solid Oral Dosage Forms Gerard M. Bredael 1,*, Steve Liang 2, and David Hahn 3 1 Pharmaceutical
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL DISSOLUTION This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control
More informationThe role and future of dissolution testing in a QBD product development framework
The role and future of dissolution testing in a QBD product development framework Paul Dickinson, AstraZeneca, Alderley Park, Cheshire Senior Clinical Pharmacology Scientist paul.dickinson@astrazeneca.com
More informationMethacrylic acid ethyl acrylate copolymer (1:1) dispersion 30 per cent (e.g. Kollicoat MAE 30 DP)
Investigating the effect of partial neutralisation of the polymer on the dissolution characteristics of poly(methacrylic acid-co-ethyl acrylate) based coats Carolina Corell 1,3 ; Florian Bang 1 ; Thorsten
More informationWHO DRAFT PHARMACEUTICAL DEVELOPMENT FOR MULTISOURCE (GENERIC) PHARMACEUTICAL PRODUCTS
23 April 2008 Quality Assurance Programme Quality Assurance and Safety: Medicines (QSM) Department of Medicines Policy and Standards (PSM) World Health Organization CH-1211 Geneva 27 Switzerland WHO DRAFT
More informationPhase Appropriate Method Validation
Phase Appropriate Method Validation Aryo Nikopour Irvine, California January 12, 2017 The Southern California Pharmaceutical Discussion Group (SCPDG) of AAPS OUTLINE What is Validation Guidelines Method
More informationApplication Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau
Development, validation, and comparison of an HPLC method to analyze paracetamol and related impurities according to the European Pharmacopoeia (EP) and USP using the Agilent 1120 Compact LC and the Agilent
More informationBCS Guidance and Biowaivers BCS Monographs
BCS Guidance and Biowaivers BCS Monographs Vinod P. Shah, Ph.D., Pharmaceutical Consultant PQRI Board Member 2 nd FDA/PQRI Conference on Advancing Product Quality Emerging Regulatory Initiatives Biopharmaceutics
More informationPAI Inspections, Observations and Data Integrity
PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November
More informationDevelopment and Validation of Isoniazid in Bulk and Pharmaceutical Dosage Forms by UFLC Method
DOI:10.21276/ijprhs.2019.01.09 Shailendra et al. CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original
More informationDevelopment and validation of stability indicating RP-HPLC method for the estimation of Daclatasvir in bulk and formulation
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (15):107-113 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationQuantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) in quetiapine fumarate by gas chromatogaraphy
Advances in Bioscience and Biotechnology, 2010, 1, 367-371 doi:10.4236/abb.2010.15049 Published Online December 2010 (http://www.scirp.org/journal/abb/). Quantitative determination of residual 2-(2-chloroethoxy)
More informationRegulatory Expectations, Standards & Guidelines
Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory
More informationBIOPHARMACEUTICS CLASSIFICATION SYSTEM-BASED BIOWAIVERS - M9
BIOPHARMACEUTICS CLASSIFICATION - M9 Step 2 document to be released for comments Date 7 June 2018 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 Legal
More informationThe use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible?
The use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible? Limin Zhang (Bristol-Myers Squibb Company) Andre Hermans (Merck & Co., Inc.) 2017 M-CERSI Workshop
More informationFusion AE. Analytical Method Development And Method Validation
Analytical Method Development And Method Validation Automated Experimentation Chemometric platform for analytical method development and validation. Auto-control of instrument parameters, external solvent
More informationRegulatory Requirements of Dissolution for Generic Drug Products
Regulatory Requirements of Dissolution for Generic Drug Products Om Anand, Ph.D. Division of Biopharmaceutics, Office of New Drug Products, Office of Pharmaceutical Quality - CDER, US-FDA International
More informationIntercontinental journal of pharmaceutical Investigations and Research
Available online at ISSN: 2349-5448 Intercontinental journal of pharmaceutical Investigations and Research ICJPIR Volume 4 Issue 1 Jan Mar- 2017 Research Article A new analytical method development and
More informationCOMMON DEFICIENCIES IN FINISHED PHARMACEUTICAL PRODUCT (FPP) DOSSIERS
COMMON DEFICIENCIES IN FINISHED PHARMACEUTICAL PRODUCT (FPP) DOSSIERS Additional guidance for manufacturers This note identifies the most common quality related deficiencies in recently assessed dossiers
More informationNIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production
NIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production Slash release times with NIR Innovative features Fully automatic assay of tablet weight, hardness,
More informationShort Communication Stability Indicating Assay Method Development and Validation of Tolteridone Tartrate in Bulk Drug and Capsules
Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Short Communication Stability Indicating Assay Method Development and Validation of Tolteridone Tartrate in Bulk Drug and Capsules V Asha Ranjani 1 *, T Prabhakar
More informationFusionChrom. Analytical Method Development And Method Validation
Analytical Method Development And Method Validation Automated Experimentation Chemometric platform for analytical method validation. Auto-control of instrument parameters, external solvent selection valves,
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory. Uganda (NDQCL-NDA) Mulago Hill, P.O. Box 23096, Kampala, Uganda. NDA,
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory Part
More informationCHAPTERS 1, 2 and 3 CHAPTER-4 CHAPTER-5,
319 Presently in the pharmaceutical industry, drug analysis plays a vital role in deciding the quality and potency of the drug. The selection of analytical method used to quantify the drugs and impurities
More informationDissolution and clinically relevant specifications: linking clinical performance to dissolution
Dissolution and clinically relevant specifications: linking clinical performance to dissolution Talia Flanagan, Dave Holt, Paul Dickinson, Paul Stott. FDA/PQRI Conference on Evolving Product Quality 16-17
More informationAn Automated System for At-Line Process Analysis of Biopharmaceutical Fermentation Reactions
An Automated System for At-Line cess Analysis of Biopharmaceutical Fermentation Reactions Frank Steiner, Susanne Fabel, Fraser McLeod, Dionex Corporation, Germering, Germany Abstract Monitoring amino acid
More informationMulti-element determination in pharmaceutical preparations using the Thermo Scientific icap Q ICP-MS
Multi-element determination in pharmaceutical preparations using the Thermo Scientific icap Q ICP-MS Dr. Simon Nelms, Thermo Fisher Scientific, UK Application Note 43100 Key Words icap Q, Pharmaceutical
More informationInternational Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: , ISSN(Online): Vol.10 No.6, pp , 2017
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.6, pp 1073-1082, 2017 Cost Effective Stabilty Indicating Reverse Phase High Performance
More informationPortfolio Overview Galenic Instruments
Galenic Instruments Portfolio Overview Galenic Instruments www.pharma-test.com Galenic Instruments For over 35 years, Pharma Test has been synonymous with the development and production of high-value test
More informationDissolution Apparatus Types
Dissolution Apparatus Types Thank you for reading. As you may know, people have look numerous times for their favorite books like this, but end up in infectious downloads. Rather than enjoying a good book
More informationAvailable Online through (or) IJPBS Volume 2 Issue 3 JULY-SEPT Research Article Pharmaceutical Sciences
Page1 Research Article Pharmaceutical Sciences RP-HPLC DETERMINATION OF RELATED SUBSTANCES OF TAPENTADOL IN BULK AND PHARMACEUTICAL DOSAGE FORM EDIGA SASI KIRAN GOUD* 1, V.KRISHNA REDDY 2 * 1,2 Department
More informationEnhanced Mechanical Calibration of Dissolution Test Equipment
dx.doi.org/10.14227/dt180211p25 Enhanced Mechanical Calibration of Dissolution Test Equipment Alger Salt 1, * and John Glennon 2 1 GlaxoSmithKline, Product Development Laboratory Automation and Platforms,
More informationFusion Analytical Method Validation
Fusion QbD Software System Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationDevelopment of Quality Control Method for Dissolution Analysis of Tapentadol and paracetamolin tablet
Original Research Article Development of Quality Control Method for Dissolution Analysis of Tapentadol and paracetamolin tablet Krishna R Gupta 1,*, Kiran N. Kale 2 1 Professor, 2 Phd. Scholar, SKB College
More informationLifecycle Product Quality Risk Management
Lifecycle Product Quality Risk Management Richard L. Friedman, M.S. Associate Director Office of Manufacturing and Product Quality Office of Compliance IFPAC Annual Meeting (Arlington, VA) January, 21-24,
More informationJournal of Pharmaceutical and Bioanalytical Science
Journal of Pharmaceutical and Bioanalytical Science Research Article Stability-Indicating RP-HPLC Method for Estimation of Erdosteine and its Degradation Products in Pharmaceutical Dosage Form Anita P.
More informationAnalytical Method Development and Validation for the Estimation of Abiraterone and its Impurity in Pharmaceutical Formulation By RP-HPLC
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2018, 10 [9]: 19-31 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4
More informationCRITICAL ASPECT ANALYTICAL TEST REVIEW
CRITICAL ASPECT ANALYTICAL TEST REVIEW Jakarta 14 December 2017 Speaker: HERU PURNOMO, ST QC WORK FLOW Start Sample Received (In-Process & Finished Good) Testing Review Lab Result Yes No Non Conformance
More informationTECHNICAL INFORMATION
T-1860A TECHNICAL INFORMATION Capillary Electrophoresis PRECISION IN CAPILLARY ELECTROPHORESIS Harry Whatley and Jeff Chapman Beckman Coulter, Inc. Introduction Instrumentation for routine chemical analysis
More informationThe Agilent StreamSelect LC/MS Solution: Increasing the Throughput of a Triple Quadrupole Mass Spectrometer
The Agilent StreamSelect LC/MS Solution: Increasing the Throughput of a Triple Quadrupole Mass Spectrometer Technical Overview Introduction Liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS)
More informationAlkermes Contract Pharma Services
Alkermes Contract Pharma Services Highly Potent, Poorly Soluble Product Manufacturing Contract, with 100% OTIF #501 April 2013 Fidelma Callanan Senior Director, Marketing and Commercial Development Contents
More information